Strategic collaboration combines germline genetic testing, next-generation tumor sequencing and world-class testing capabilities to elevate global precision oncology care SALT LAKE CITY — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a new strategic precision oncology collaboration with Intermountain Precision Genomics, a service of Intermountain Healthcare. This collaboration […]
Mobile platform intended to produce >1,000s of ready-to-use doses at the site of need in under 3 days Project leverages GE’s expertise regarding synthetic method for producing industrial amounts of DNA GE’s DNA-based approach could be compatible with new, recently approved RNA-based COVID-19 vaccines NISKAYUNA, NY – March 2, 2021 – Aiming to enable vaccine production […]
Highlights: Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with Agilent’s leadership in tissue-based companion diagnostics and global commercial and regulatory scale. Furthers Agilent’s participation in fast-growing NGS technologies for precision oncology, expanding Agilent’s addressable market by […]
SOUTH SAN FRANCISCO, Calif. & BOULDER, Colo. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Watchmaker Genomics today announced a broad partnership to enable innovative research across a wide range of high throughput sequencing applications including oncology and tumor […]
SOUTH SAN FRANCISCO, Calif. and PARIS — DNA Script, a leading pioneer in enabling DNA synthesis on demand, today announced that the company has been selected by GE Research to join a collaboration to develop a rapid response, mobile medical manufacturing platform to enable on-demand production of nucleic acid-based vaccines and therapies. The $41-million, five-year project was awarded as […]
ST. LOUIS, MO. — PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinforce the company’s position as the leading provider of clinical genomics solutions in the fight against cancer and hereditary disease. She will also head […]
Company is showcasing advantages of the automated Ionic® Complete FFPE Purification Kit during the virtual AGBT 2021 meeting Pleasanton, Calif. – Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from biological samples, today announced the launch of the Ionic® FFPE Complete Purification Kit. Scientists are now able to consistently recover […]
Solution delivers end-to-end single-cell analysis in an intuitive web-based interface ROSALIND, a leader in extracting meaningful insights from diverse pools of life science data, today announced the commercial launch of its new solution for single cell data analysis. The new analysis module, which enables web-based collaboration and the analysis and interpretation of 10X Genomics-generated single […]
Transaction Expands and Diversifies Hologic’s Diagnostic Business Across Test Menu, Customer Segments and Geography MARLBOROUGH, Mass. — Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has acquired Diagenode, a privately held, European developer and manufacturer of molecular diagnostic assays and epigenetics products, for approximately $159 million (130 million euros), […]
OmniTier announced today that its CompStor® family now supports mitochondrial analysis in both its secondary and tertiary analysis appliances. Accurate identification of the mitochondrial genome and its translocations into the nuclear genome are key requirements for researchers and clinicians seeking to improve their understanding of mitochondrial dysfunction. CompStor Novos® now generates small-variant identification that is […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
